Mark Schoenberg, Chief Medical Officer at UroGen Pharma Ltd. (URGN), sold 1,374 shares at $7.58 ($10K) on 2022-01-31, disclosed to the SEC on 2022-02-02.
Open-market sale of $10k URGN by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.58 | 275 | $2K | 20.0% |
| 2 | $7.58 | 1,099 | $8K | 80.0% |
| Total | $7.58 avg | 1,374 | $10K | 100% |
| Filing → |
| URGN | SELL | 2026-07-10 | $400K | — | Filing → |
| URGN | SELL | 2026-06-24 | $350K | — | Filing → |
| URGN | SELL | 2026-06-09 | $143K | — | Filing → |